BiomX
Microbiome drug discovery company developing customized phage therapies for chronic diseases.
About
Technology stack
detected 2026-06-12No comments yet. Be the first to share your take.
What does BiomX do?
BiomX is a microbiome drug discovery company focused on developing customized phage therapies. They target and destroy harmful bacteria implicated in chronic diseases such as inflammatory bowel disease (IBD) and cancer. The company discovers and validates proprietary bacterial targets and customizes natural and engineered phages to address these conditions.
How much funding has BiomX raised?
BiomX has raised a total of $56M in funding. The most recent round on record is Series B.
Where is BiomX headquartered?
BiomX is headquartered in Ness Ziona, Israel.
When was BiomX founded?
BiomX was founded in 2017.
What industry does BiomX operate in?
BiomX operates in Healthcare, Drug Discovery, Biotech, Phage Therapy, Microbiome Engineering, HealthTech.
How many employees does BiomX have?
BiomX has approximately 104 people on record.